Osteopathic Manipulative Treatment
Conditions
Brief summary
The goal of this clinical trial is to learn if osteopathic manipulative techniques add benefits for treatment of patients with progressive pulmonary fibrosis. The main questions it aims to answer are : Could osteopathic manipulative techniques add benefits for treatment of patients with progressive pulmonary fibrosis? Researchers will compare osteopathic manipulative techniques with chest physiotherapy to chest physiotherapy alone to see if osteopathic manipulative techniques works to treat progressive pulmonary fibrosis. Participants will: Take osteopathic manipulative techniques 2 days a week for 4 weeks and chest physiotherapy 3 days a week for 4 weeks
Detailed description
In this study researchers want to see if osteopathic manipulative techniques add benefits to treat progressive pulmonary fibrosis. two group of patients : study group will receive osteopathic manipulative techniques with conventional chest physiotherapy . control group will receive only conventional chest physiotherapy . osteopathic manipulative techniques will be done for 2 days a week for 4 weeks while conventional chest physiotherapy will be done 3 days a week for 4 weeks.
Interventions
OTHERosteopathic manipulative techniques
for 4 weeks , 2 sessions per week
for 4 weeks , 3 sessions per week
Sponsors
Beni-Suef University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Their age \> 18. * Both sexes. * Patients without excerbations. * FVC of the patient \<50% . * FEV1/ FVC of the patient \<50%. * Hemodynamic stable. * Conscious and cooperative. * Are able to participate in training actively.
Exclusion criteria
* Patients with acute excerbations. * Acute or Uncontrolled Infections. * Active Malignancy. * Chest deformity
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| pulmonary function test - FVC | preintervention , post intervention after 4 weeks | FVC |
| pulmonary function test - FEV | pre intervention , post intervention after 4 weeks | FEV |
| pulmonary function test - FEV/FVC | pre intervention , post intervention after 4 weeks | FEV/FVC |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| chest expansion measurment | pre intervention , post intervention after 4 weeks | — |
| Modified Medical Research Council dyspnea scale | pre intervention , post intervention after 4 weeks | Minimum value: 0 Maximum value:4 Higher scores indicate a worse outcome (more severe dyspnea) |
Countries
Egypt
Contacts
CONTACTOla A Mohamed
CONTACTTamer I Abo elyazed, professor
PRINCIPAL_INVESTIGATORTamer I Abo elyazed, professor
Beni-Suef University
Outcome results
None listed